Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q2 EPS of ($0.79), $0.13 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.